New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo

Medicine & Life Sciences

1. Hepacivirus 100%
2. T-Lymphocytes 66%
3. T-Lymphocyte Subsets 57%
4. Liver 55%
5. Natural Killer T-Cells 51%
6. Immunity 44%
7. Antiviral Agents 36%
8. Viruses 35%
9. Liver Diseases 27%
10. Hepatocytes 27%
11. Lymphocyte Subsets 24%
12. Virus Diseases 23%
13. Infections 20%
14. Chronic Hepatitis C 11%
15. Gene Expression Profiling 11%
16. Liver Cirrhosis 9%
17. Disease Progression 8%
18. Flow Cytometry 8%
19. Vaccines 8%
20. Kinetics 7%
21. Animal Models 7%
22. Carcinoma 7%
23. Pathology 6%
24. Cytokines 6%
25. Inflammation 6%
26. Wounds and Injuries 5%